HIMS - Hims & Hers Health, Inc.
Price:
--
--
|
CONSENSUS:
Hold
DETAILS
|
PRICE TARGET:
$26.27
DETAILS
HIGH:
$60.00
LOW:
$12.50
MEDIAN:
$24.50
CONSENSUS:
$26.27
UPSIDE:
10.61%
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Revenue | |||||||
| Revenue | 2,347.6 | 1,476.5 | 872 | 526.9 | 271.9 | 148.8 | 82.6 |
| Cost of Revenue | 614.3 | 303.4 | 157.1 | 118.2 | 67.4 | 39.3 | 38.0 |
| Gross Profit | 1,733.4 | 1,173.1 | 714.9 | 408.7 | 204.5 | 109.5 | 44.6 |
| Operating Expenses | |||||||
| R&D Expenses | 149.3 | 78.8 | 48.2 | 29.2 | 22.4 | 11.2 | 0 |
| SG&A Expenses | 1,192.0 | 846.6 | 576.3 | 370.8 | 249.6 | 113.4 | 119.0 |
| Other Expenses | 286.4 | 185.8 | 119.9 | 77.4 | 47.6 | 0 | 0 |
| Operating Expenses | 1,627.8 | 1,111.2 | 744.4 | 477.4 | 319.5 | 124.6 | 119.0 |
| Operating Income | |||||||
| Operating Income | 105.6 | 61.9 | (29.5) | (68.7) | (115.0) | (15.1) | (74.4) |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0.0 | 0.4 |
| Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profitability | |||||||
| EBITDA | 160.1 | 79.0 | (19.9) | (61.2) | (111.0) | (14.1) | (71.3) |
| EBIT | 105.6 | 61.9 | (29.5) | (68.7) | (115.0) | (15.1) | (71.6) |
| Income Before Tax | 123.9 | 71.7 | (21.6) | (65.7) | (110.8) | (18.0) | (72.0) |
| Income Tax Expense | (4.4) | (54.3) | 2.0 | (0.0) | (3.1) | 0.1 | 0.1 |
| Net Income | 128.4 | 126.0 | (23.5) | (65.7) | (107.7) | (18.1) | (72.1) |
| Per Share Data | |||||||
| EPS (Basic) | 0.57 | 0.58 | -0.11 | -0.32 | -0.58 | -0.51 | -2.07 |
| EPS (Diluted) | 0.51 | 0.53 | -0.11 | -0.32 | -0.58 | -0.51 | -2.07 |
| Shares Outstanding | 225.0 | 215.9 | 209.3 | 204.5 | 186.8 | 35.4 | 34.8 |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Current Assets | |||||||
| Cash & Cash Equivalents | 228.6 | 220.6 | 96.7 | 46.8 | 71.8 | 27.3 | 22.6 |
| Short-Term Investments | 348.9 | 79.7 | 124.3 | 132.9 | 175.5 | 72.9 | 37.7 |
| Net Receivables | 32.1 | 6.1 | 6.7 | 3.2 | 3.6 | 0.8 | 0.9 |
| Inventory | 115.7 | 64.4 | 22.5 | 21.6 | 13.6 | 3.5 | 4.2 |
| Other Current Assets | 4.4 | 8.9 | 4.2 | 1.8 | 0.9 | 5.9 | 0.5 |
| Total Current Assets | 767.6 | 395.8 | 265.1 | 216.6 | 269.9 | 113.1 | 69.6 |
| Non-Current Assets | |||||||
| Property, Plant & Equipment | 449.0 | 93.0 | 45.7 | 16.1 | 5.1 | 0 | 0 |
| Goodwill | 278.3 | 112.7 | 110.9 | 110.9 | 110.9 | 0 | 0 |
| Intangible Assets | 196.1 | 43.4 | 18.6 | 21.8 | 25.9 | 0.1 | 0 |
| Long-Term Investments | 351.3 | 0 | 0 | 0 | 0 | 204.5 | 0 |
| Other Non-Current Assets | 29.7 | 1.0 | 0.9 | 0.9 | 8.8 | (199.0) | 2.5 |
| Total Non-Current Assets | 1,387.1 | 311.7 | 176.1 | 149.7 | 150.7 | 5.6 | 2.5 |
| Total Assets | 2,154.7 | 707.5 | 441.2 | 366.3 | 420.6 | 118.7 | 72.1 |
| Current Liabilities | |||||||
| Account Payables | 143.3 | 91.2 | 43.1 | 32.4 | 19.6 | 8.1 | 7.2 |
| Short-Term Debt | 4.8 | 0 | 0 | 0 | 0 | 0 | 1.5 |
| Deferred Revenue | 127.2 | 75.3 | 7.7 | 1.5 | 3.2 | 1.3 | 0.8 |
| Other Current Liabilities | 103.4 | 0 | 0 | 0 | 0 | 1.6 | 9.1 |
| Total Current Liabilities | 404.4 | 221.4 | 88.5 | 47.9 | 79.2 | 15.2 | 20.6 |
| Non-Current Liabilities | |||||||
| Long-Term Debt | 1,115.7 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 28.9 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | (78.4) | 0 | 0.0 | 3.0 | 2.6 | 250.3 | 186.7 |
| Total Non-Current Liabilities | 1,209.3 | 9.5 | 8.7 | 6.7 | 6.7 | 250.3 | 186.7 |
| Total Liabilities | 1,613.8 | 230.8 | 97.2 | 54.6 | 86.0 | 265.6 | 207.4 |
| Stockholders' Equity | |||||||
| Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 4.5 |
| Retained Earnings | (113.8) | (242.1) | (368.2) | (344.6) | (279.0) | (171.3) | (153.2) |
| Accumulated Other Comprehensive Income | 2.3 | (0.3) | (0.1) | (0.3) | (0.1) | (0.0) | 0.0 |
| Total Stockholders' Equity | 540.9 | 476.7 | 344.0 | 311.7 | 334.6 | (146.9) | (135.3) |
| Total Liabilities & Equity | 2,154.7 | 707.5 | 441.2 | 366.3 | 420.6 | 118.7 | 72.1 |
| Debt Metrics | |||||||
| Total Debt | 1,263.8 | 11.3 | 9.9 | 5.3 | 5.5 | 0 | 1.5 |
| Net Debt | 1,035.1 | (209.2) | (86.7) | (41.5) | (66.3) | (27.3) | (21.1) |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||
| Net Income | 128.4 | 126.0 | (23.5) | (65.7) | (107.7) | (18.1) | (72.1) |
| Depreciation & Amortization | 54.5 | 17.1 | 9.5 | 7.5 | 4.1 | 1.1 | 0.3 |
| Stock-Based Compensation | 135.2 | 92.3 | 66.1 | 42.8 | 67.2 | 5.8 | 8.0 |
| Change in Working Capital | (29.2) | 78.6 | 20.8 | (14.2) | 3.5 | 4.2 | (9.9) |
| Other Non-Cash Items | 24.0 | (1.3) | 0.6 | 3.6 | 1.9 | 4.6 | (1.2) |
| Operating Cash Flow | 300.0 | 251.1 | 73.5 | (26.5) | (34.4) | (2.5) | (74.9) |
| Investing Activities | |||||||
| Capital Expenditure | (226.0) | (52.8) | (26.5) | (7.2) | (5.0) | (4.2) | (1.8) |
| Acquisitions | (145.2) | (15.4) | 0 | (0.5) | (46.5) | 0 | 0 |
| Purchases of Investments | (745.8) | (160.6) | (157.2) | (187.7) | (266.6) | (95.0) | (42.0) |
| Sales/Maturities of Investments | 108.7 | 209.7 | 171.6 | 230.1 | 161.8 | 59.5 | 4.5 |
| Other Investing Activities | (16.5) | (11.1) | (9.3) | (4.5) | (4.2) | (2.5) | (1.5) |
| Investing Cash Flow | (1,025.0) | (19.0) | (12.1) | 34.7 | (156.3) | (39.7) | (39.3) |
| Financing Activities | |||||||
| Net Debt Issuance | 918.8 | 0 | 0 | 0 | 1.2 | (1.5) | (6.9) |
| Stock Repurchased | (90.0) | (83.0) | (2.0) | 0 | (22.0) | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (116.7) | (24.8) | (9.5) | (33.1) | (16.8) | (2.6) | (0.3) |
| Financing Cash Flow | 729.6 | (107.8) | (11.5) | (33.1) | 235.0 | 47.7 | 95.3 |
| Cash Position | |||||||
| Net Change in Cash | 8.0 | 123.9 | 49.9 | (25.0) | 44.3 | 5.6 | (18.9) |
| Cash at Beginning | 221.4 | 97.5 | 47.6 | 72.6 | 28.4 | 22.8 | 41.6 |
| Cash at End | 228.6 | 221.4 | 97.5 | 47.6 | 72.6 | 28.4 | 22.8 |
| Free Cash Flow | 74.0 | 198.3 | 47.0 | (33.8) | (39.4) | (6.7) | (76.7) |
| Key Metrics | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Income Statement | |||||||
| Revenue | 2,347.6 | 1,476.5 | 872 | 526.9 | 271.9 | 148.8 | 82.6 |
| Gross Profit | 1,733.4 | 1,173.1 | 714.9 | 408.7 | 204.5 | 109.5 | 44.6 |
| Operating Income | 105.6 | 61.9 | (29.5) | (68.7) | (115.0) | (15.1) | (74.4) |
| Net Income | 128.4 | 126.0 | (23.5) | (65.7) | (107.7) | (18.1) | (72.1) |
| EPS (Diluted) | 0.51 | 0.53 | -0.11 | -0.32 | -0.58 | -0.51 | -2.07 |
| Balance Sheet | |||||||
| Cash & Equivalents | 228.6 | 220.6 | 96.7 | 46.8 | 71.8 | 27.3 | 22.6 |
| Total Assets | 2,154.7 | 707.5 | 441.2 | 366.3 | 420.6 | 118.7 | 72.1 |
| Total Debt | 1,263.8 | 11.3 | 9.9 | 5.3 | 5.5 | 0 | 1.5 |
| Stockholders' Equity | 540.9 | 476.7 | 344.0 | 311.7 | 334.6 | (146.9) | (135.3) |
| Cash Flow | |||||||
| Operating Cash Flow | 300.0 | 251.1 | 73.5 | (26.5) | (34.4) | (2.5) | (74.9) |
| Capital Expenditure | (226.0) | (52.8) | (26.5) | (7.2) | (5.0) | (4.2) | (1.8) |
| Free Cash Flow | 74.0 | 198.3 | 47.0 | (33.8) | (39.4) | (6.7) | (76.7) |